CLDN2 and inflammatory bowel disease: demonstrated that macrophage-specific PTPN2 deficiency promotes IL-6 upregulation, reducing the expression of tight junction proteins (Claudin-2, occludin) and increasing colonic permeability in mice, thereby elevating the risk of inflammatory bowel disease (IBD) (44).